Breast Cancer Treatment that gives her 15 years of good quality of life and cancer free

When Mrs. Soenariningsih was diagnosed with breast cancer, she was not interested in calculating survival percentages in breast cancer treatment or reading medical statistics. What mattered to her was much simpler: she wanted to recover, remain independent, and continue living a healthy and meaningful life without being overwhelmed by the side effects of treatment.

She was diagnosed with invasive lobular carcinoma (ILC), Grade 1, a hormone-related subtype of breast cancer that generally grows slowly and is considered less aggressive than higher-grade disease. Following medical advice, she underwent surgery, chemotherapy, and continued long-term endocrine therapy as recommended by her doctors to reduce the risk of recurrence.

At the same time, she decided to incorporate ECCT into her care as a complementary approach.

Her decision was influenced in part by a deeply personal experience. Ten years earlier, her husband had passed away from lymphoma only two weeks after surgery, before he had the opportunity to receive chemotherapy or explore other supportive therapies. That experience left a lasting impression on her and strengthened her determination to do everything she considered reasonable and beneficial for her own health.

Mrs. Soenariningsih began using ECCT during its earliest developmental years and has continued to use it consistently alongside her prescribed endocrine medication. She understood that no therapy can scientifically guarantee a 100 percent cure, but she believed that combining standard medical treatment with supportive therapies offered her the best opportunity to achieve a better long-term outcome.

Today, nearly two decades later, she is approaching her 80th birthday and remains remarkably active. A retired midwife, she continues to lead a church choir of twenty members and teaches music to children. She frequently travels independently. What she values most is not simply being alive, but maintaining the quality of life she enjoys today.

Despite many years of endocrine therapy, she reports not experiencing some of the common long-term side effects often associated with anti-hormonal treatment, such as osteoporosis, fractures, severe joint pain, debilitating fatigue, or significant limitations in her daily activities.

She believes that long-term ECCT use has contributed positively to her overall well-being and has helped her maintain an active lifestyle throughout her cancer journey.

At present, her greatest concern is not cancer, but whether she will still be allowed to ride her motorcycle after turning eighty next year. For Mrs. Soenariningsih, cancer became not the end of an active life, but the beginning of a new chapter, one defined by resilience, purpose, faith, and the determination to continue doing the things she loves.

Individual experiences vary and cannot establish causation. Standard treatments such as surgery, systemic therapy, and endocrine therapy remain the foundation of evidence-based breast cancer care. This story reflects one patient's personal experience using ECCT alongside conventional treatment.